Biofourmis, a company with offices in Singapore and Boston, won FDA clearance for its RhythmAnalytics cloud-based software that uses artificial intelligence techniques to automate the interpretation of cardiac arrhythmias from ECG tracings. The system can detect more than fifteen different types of arrhytmias including using beat-by-beat morpholog (Read more...)